Interim report Q2 2024

Now available

Read the Bactiguard Holding AB (publ) interim report for the second quarter and re-watch the audiocast with CEO Christine Lind and CFO Patrick Bach below.

To the audiocast Report Presentation
Annual and Sustainability Report 2023

Annual and Sustainability Report 2023

To the Annual and Sustainability Report 2023

The Bactiguard Technology

The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

Learn more about the technology

Purpose

To champion a healthier world by preventing infections.

Vision

To be the global standard of care for preventing medical device related infections.

Mission

To be the premier partner for leading MedTech companies, joining forces to redefine healthcare and improve health worldwide.

Core values

  • Respect
  • Trust
  • Transparency
  • Performance

Bactiguard is a purpose-driven company with a strong corporate culture, firmly anchored in four core values. The values are an integral part of Bactiguard’s purpose to champion a healthier world by preventing infections and a prerequisite to achieve our targets.

Press releases

All press releases

The share

Bactiguard as an investment

The ambition is to become a profitable knowledge and specialist organization which is a prerequisite to deliver on our financial, strategic and sustainability targets.

Three reasons to invest in Bactiguard

Calendar
  • 24
    Oct 2024

    Interim report Q3 July 1 – September 30 2024

  • 19
    Nov 2024

    Bactiguard presents at SEB Healthcare Seminar in Stockholm

Media & Investor Relations

  • Nina Nornholm

    Nina Nornholm

    Head of Corporate Communication & Investor Relations

    +46 70 855 0356